Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine

被引:10
作者
Ghanian, Zahra [1 ]
Maleki, Sepideh [1 ]
Reiland, Hannah [2 ]
Buetz, Daniel E. [3 ]
Chiellini, Grazia [2 ]
Porter, Fariba-Assadi [2 ,4 ]
Ranji, Mahsa [1 ]
机构
[1] Univ Wisconsin, Dept Elect Engn & Comp Sci, Biophoton Lab, Milwaukee, WI 53211 USA
[2] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
[3] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA
[4] Univ Wisconsin, NMR Facil Madison, Madison, WI 53706 USA
关键词
3-Iodothyronamine; optical imaging; NADH; FAD; mitochondrial redox ratio; oxidative stress; RAT-LIVER MITOCHONDRIA; THYROID-HORMONE; VIVO; REDUCTION; HEART; MICE; REPERFUSION; ISCHEMIA; CAPACITY; GLUCOSE;
D O I
10.1177/1535370213510252
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study used an optical technique to measure the effects of treating low (10 mg/kg) and high (25 mg/kg) doses of 3-iodothyronamine (T(1)AM) on the metabolism in the kidney and heart of mice. The ratio of two intrinsic fluorophores in tissue, (NADH/FAD), called the NADH redox ratio (NADH RR), is a marker of the metabolic state of the tissue. A cryofluorescence imaging instrument was used to provide a quantitative assessment of NADH RR in both kidneys and hearts in mice treated with 3-iodothyronamine. We compared those results to corresponding tissues in control mice. In the kidneys of mice treated with a high dose T(1)AM, the mean values of the maximum projection of NADH RR were 2.6 +/- 0.6 compared to 3.20 +/- 0.03 in control mice, indicating a 19% (+/- 0.4) significant increase in oxidative stress (OS) in the high dose-treated kidneys (P = 0.047). However, kidneys treated with a low dose of T(1)AM showed no difference in NADH RR compared to the kidneys of control mice. Furthermore, low versus high dose treatment of T(1)AM showed different responses in the heart than in the kidneys. The mean value of the maximum projection of NADH RR in the heart changed from 3.0 +/- 0.3 to 3.2 +/- 0.6 for the low dose and the high dose T(1)AM-treated mice, respectively, as compared to 2.8 +/- 0.7 in control mice. These values correspond to a 9% (+/- 0.5) (P = 0.045) and 14% (+/- 0.5) (P = 0.008) significant increase in NADH RR in the T(1)AM-treated hearts, indicating that the high dose T1AM- treated tissues have reduced OS compared to the low dose-treated tissues or the control tissues. These results suggest that while T1AM at a high dose increases oxidative response in kidneys, it has a protective effect in the heart and may exert its effect through alternative pathways at different doses and at tissue specific levels.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 42 条
[1]   Modulation of Mitochondrial Bioenergetics in the Isolated Guinea Pig Beating Heart by Potassium and Lidocaine Cardioplegia: Implications for Cardioprotection [J].
Aldakkak, Mohammed ;
Stowe, David F. ;
Lesnefsly, Edward J. ;
Heisner, James S. ;
Chen, Qun ;
Camara, Amadou K. S. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 54 (04) :298-309
[2]  
Avi-Dor Y., 1962, BIOL CHEM, V237, P7
[3]   3-iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation [J].
Braulke, L. J. ;
Klingenspor, M. ;
DeBarber, A. ;
Tobias, S. C. ;
Grandy, D. K. ;
Scanlan, T. S. ;
Heldmaier, G. .
JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMIC AND ENVIRONMENTAL PHYSIOLOGY, 2008, 178 (02) :167-177
[4]   INTRACELLULAR OXIDATION- REDUCTION STATES IN VIVO [J].
CHANCE, B ;
JOBSIS, F ;
SCHOENER, B ;
COHEN, P .
SCIENCE, 1962, 137 (3529) :499-&
[5]  
CHANCE B, 1979, J BIOL CHEM, V254, P4764
[6]   Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function [J].
Chiellini, Grazia ;
Frascarelli, Sabina ;
Ghelardoni, Sandra ;
Carnicelli, Vittoria ;
Tobias, Sandra C. ;
DeBarber, Andrea ;
Brogioni, Simona ;
Ronca-Testoni, Simonetta ;
Cerbai, Elisabetta ;
Grandy, David K. ;
Scanlan, Thomas S. ;
Zucchi, Riccardo .
FASEB JOURNAL, 2007, 21 (07) :1597-1608
[7]   Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors [J].
Chiellini, Grazia ;
Erba, Paola ;
Carnicelli, Vittoria ;
Manfredi, Chiara ;
Frascarelli, Sabina ;
Ghelardoni, Sandra ;
Mariani, Giuliano ;
Zucchi, Riccardo .
JOURNAL OF ENDOCRINOLOGY, 2012, 213 (03) :223-230
[8]   Mitochondrial F0F1-ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone [J].
Cumero, S. ;
Fogolari, F. ;
Domenis, R. ;
Zucchi, R. ;
Mavelli, I. ;
Contessi, S. .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (08) :2331-2347
[9]   Prevalence of Endocrine Diseases in Morbidly Obese Patients Scheduled for Bariatric Surgery: Beyond Diabetes [J].
Fierabracci, Paola ;
Pinchera, Aldo ;
Martinelli, Silvia ;
Scartabelli, Giovanna ;
Salvetti, Guido ;
Giannetti, Monica ;
Pucci, Andrea ;
Galli, Giulia ;
Ricco, Ilaria ;
Querci, Giorgia ;
Rago, Teresa ;
Di Salvo, Claudio ;
Anselmino, Marco ;
Vitti, Paolo ;
Santini, Ferruccio .
OBESITY SURGERY, 2011, 21 (01) :54-60
[10]   Cardioprotective Effect of 3-Iodothyronamine in Perfused Rat Heart Subjected to Ischemia and Reperfusion [J].
Frascarelli, Sabina ;
Ghelardoni, Sandra ;
Chiellini, Grazia ;
Galli, Elena ;
Ronca, Francesca ;
Scanlan, Thomas S. ;
Zucchi, Riccardo .
CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (04) :307-313